GlassScriptPhysician profile
David Patrick John Garry
NPI 1497702252
$1,295.64
in general payments reported to CMS, 2019-2025
21 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $194 · 2021: $34.88 · 2022: $442 · 2023: $172 · 2024: $30.24 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $350.85 | 2019-2025 | Phasix Mesh, Arista |
| Tela Bio, INC. | $227.72 | 2022 | |
| Varian Medical Systems, INC. | $92.30 | 2020 | |
| Ethicon US, LLC | $81.71 | 2020-2025 | Echelon Circular, Echelon; Endopath, Echelon Flex |
| Depuy Synthes Sales INC. | $81.18 | 2019 | |
| Medtronic, INC. | $75.40 | 2022-2023 | Closurefast |
| Acell, INC. | $59.89 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $46.84 | 2022-2023 | |
| Kerecis Limited | $42.80 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Shire North American Group INC | $36.91 | 2019 | |
| Integra Lifesciences Corporation | $34.00 | 2022 | |
| Teleflex LLC | $21.29 | 2021 | |
| Innocoll Pharmaceuticals Limited | $20.80 | 2022 | |
| Tei Biosciences INC | $19.98 | 2019 | |
| Acera Surgical, INC. | $19.13 | 2023 | Restrata Wound Matrix |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.11 | 2023 | Bridion |
| Intuitive Surgical, INC. | $14.81 | 2020 | |
| Covidien LP | $14.43 | 2019 | |
| Edwards Lifesciences Corporation | $13.59 | 2021 | |
| Kci USA, INC. | $12.48 | 2020 | |
| Polynovo North America LLC | $12.42 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Garry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.